|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3840 SEK | 0.00% |
|
-12.33% | +20.38% |
| 05-29 | Monivent sees MDR process progressing according to plan | FW |
| 05-18 | Monivent to continue operations following initial capital sufficiency meeting | FW |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -29.72 | -40.55 | -52.04 | -57.99 | -42.55 | |||||
Return on Total Capital | -31.82 | -45.34 | -68.45 | -156.77 | -141.5 | |||||
Return On Equity % | -53.35 | -74.13 | -122.04 | -385.15 | -442.22 | |||||
Return on Common Equity | -53.35 | -74.13 | -122.04 | -385.15 | -442.22 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.92 | 59.27 | 55.51 | 65.37 | 86.09 | |||||
SG&A Margin | 609.73 | 437.38 | 425.37 | 418.36 | 257.31 | |||||
EBITDA Margin % | -658.1 | -377.96 | -382.23 | -372.44 | -183.7 | |||||
EBITA Margin % | -669.88 | -402.72 | -388.15 | -379.63 | -186.51 | |||||
EBIT Margin % | -669.88 | -402.72 | -388.15 | -379.63 | -186.51 | |||||
Income From Continuing Operations Margin % | -672.64 | -403.62 | -396.87 | -396.83 | -195.99 | |||||
Net Income Margin % | -672.64 | -403.62 | -396.87 | -396.83 | -195.99 | |||||
Net Avail. For Common Margin % | -672.64 | -403.62 | -396.87 | -396.83 | -195.99 | |||||
Normalized Net Income Margin | -420.4 | -252.26 | -248.05 | -248.02 | -122.5 | |||||
Levered Free Cash Flow Margin | -355.45 | -252.67 | -216.63 | -214.59 | -168.8 | |||||
Unlevered Free Cash Flow Margin | -352.48 | -251.74 | -210.06 | -204.13 | -164.07 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.07 | 0.16 | 0.21 | 0.24 | 0.36 | |||||
Fixed Assets Turnover | 2.16 | 5.49 | 7.82 | 11.99 | 59.86 | |||||
Receivables Turnover (Average Receivables) | 3.43 | 5.06 | 4.87 | 3.91 | 10.11 | |||||
Inventory Turnover (Average Inventory) | 1.75 | 1.06 | 0.5 | 0.21 | 0.13 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 10.67 | 7.73 | 1.48 | 1.02 | 0.88 | |||||
Quick Ratio | 10.11 | 6.65 | 0.63 | 0.31 | 0.19 | |||||
Operating Cash Flow to Current Liabilities | -6.88 | -6.78 | -2.96 | -1.46 | -1.15 | |||||
Days Sales Outstanding (Average Receivables) | 106.38 | 72.18 | 74.98 | 93.49 | 36.11 | |||||
Days Outstanding Inventory (Average Inventory) | 208.63 | 344.96 | 724.02 | 1.73K | 2.9K | |||||
Average Days Payable Outstanding | 84.04 | 45.39 | 41.29 | 83.86 | 23.43K | |||||
Cash Conversion Cycle (Average Days) | 230.97 | 371.75 | 757.71 | 1.74K | -20.49K | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.86 | 2.28 | 25.44 | 120.73 | 67.95 | |||||
Total Debt / Total Capital | 4.64 | 2.23 | 20.28 | 54.7 | 40.46 | |||||
LT Debt/Equity | 3.21 | - | 9.41 | 25.86 | 13.3 | |||||
Long-Term Debt / Total Capital | 3.06 | - | 7.5 | 11.72 | 7.92 | |||||
Total Liabilities / Total Assets | 11.66 | 12.95 | 60.89 | 88.69 | 79.24 | |||||
EBIT / Interest Expense | -141.25 | -270.25 | -36.9 | -22.68 | -24.62 | |||||
EBITDA / Interest Expense | -138.76 | -253.63 | -36.34 | -22.25 | -24.25 | |||||
(EBITDA - Capex) / Interest Expense | -138.76 | -254.53 | -36.34 | -22.25 | -24.25 | |||||
Total Debt / EBITDA | -0.08 | -0.03 | -0.09 | -0.15 | -0.22 | |||||
Net Debt / EBITDA | 1.15 | 0.9 | 0.05 | -0.06 | -0.17 | |||||
Total Debt / (EBITDA - Capex) | -0.08 | -0.03 | -0.09 | -0.15 | -0.22 | |||||
Net Debt / (EBITDA - Capex) | 1.15 | 0.89 | 0.05 | -0.06 | -0.17 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -6.45 | 95.49 | 0.29 | -17.66 | 54.11 | |||||
Gross Profit, 1 Yr. Growth % | -53.45 | 183.11 | -6.06 | -3.04 | 102.96 | |||||
EBITDA, 1 Yr. Growth % | 74.6 | 29.56 | -2.97 | -19.77 | -23.99 | |||||
EBITA, 1 Yr. Growth % | 74.1 | 17.25 | -2.98 | -19.47 | -24.29 | |||||
EBIT, 1 Yr. Growth % | 74.1 | 17.25 | -2.98 | -19.47 | -24.29 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 72.87 | 17.3 | -1.39 | -17.67 | -23.89 | |||||
Net Income, 1 Yr. Growth % | 72.87 | 17.3 | -1.39 | -17.67 | -23.89 | |||||
Normalized Net Income, 1 Yr. Growth % | 72.87 | 17.3 | -1.39 | -17.67 | -23.89 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 34.96 | 10.84 | -26.63 | -60 | -70.37 | |||||
Accounts Receivable, 1 Yr. Growth % | 233.17 | -27.56 | 47.98 | -28.42 | -56.92 | |||||
Inventory, 1 Yr. Growth % | 68.53 | 155.12 | 120 | 22.77 | -11.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -22.63 | -23.4 | -37.61 | -60.28 | -91.39 | |||||
Total Assets, 1 Yr. Growth % | -19.32 | -7.12 | -43.6 | 0.42 | 5.97 | |||||
Tangible Book Value, 1 Yr. Growth % | -21.19 | -8.46 | -74.66 | -70.95 | 94.48 | |||||
Common Equity, 1 Yr. Growth % | -21.19 | -8.46 | -74.66 | -70.95 | 94.48 | |||||
Cash From Operations, 1 Yr. Growth % | -16.75 | 29.59 | 8.93 | -27.44 | -28.33 | |||||
Capital Expenditures, 1 Yr. Growth % | - | - | - | - | - | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -46.17 | 38.58 | -13.7 | -18.44 | 21.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -46.41 | 39.23 | -16.01 | -19.98 | 23.86 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -20.32 | 35.24 | 40.02 | -9.13 | 12.65 | |||||
Gross Profit, 2 Yr. CAGR % | -46.56 | 14.79 | 63.08 | -4.56 | 40.28 | |||||
EBITDA, 2 Yr. CAGR % | 61.18 | 40.01 | 14.63 | -11.77 | -21.91 | |||||
EBITA, 2 Yr. CAGR % | 61.31 | 43.04 | 6.46 | -11.61 | -21.91 | |||||
EBIT, 2 Yr. CAGR % | 61.31 | 43.04 | 6.46 | -11.61 | -21.91 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 60.07 | 42.4 | 7.55 | -9.89 | -20.84 | |||||
Net Income, 2 Yr. CAGR % | 60.07 | 42.4 | 7.55 | -9.89 | -20.84 | |||||
Normalized Net Income, 2 Yr. CAGR % | 60.07 | 42.4 | 7.55 | -9.89 | -20.84 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -7.02 | 22.31 | -9.82 | -45.83 | -65.57 | |||||
Accounts Receivable, 2 Yr. CAGR % | - | 55.36 | 3.54 | 2.92 | -44.47 | |||||
Inventory, 2 Yr. CAGR % | - | 107.35 | 136.91 | 64.35 | 4.13 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -10.38 | -23.01 | -30.87 | -50.22 | -81.51 | |||||
Total Assets, 2 Yr. CAGR % | 45.09 | -13.43 | -27.62 | -24.74 | 3.16 | |||||
Tangible Book Value, 2 Yr. CAGR % | 244.07 | -15.06 | -51.84 | -72.87 | -24.83 | |||||
Common Equity, 2 Yr. CAGR % | 244.07 | -15.06 | -51.84 | -72.87 | -24.83 | |||||
Cash From Operations, 2 Yr. CAGR % | 118.61 | 3.87 | 18.81 | -11.1 | -27.89 | |||||
Capital Expenditures, 2 Yr. CAGR % | - | -48.07 | - | - | - | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 277.23 | -13.51 | 9.16 | -16.1 | -0.56 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 254.32 | -13.5 | 7.94 | -18.02 | -0.45 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -11.42 | 7.47 | 22.41 | 17.31 | 8.37 | |||||
Gross Profit, 3 Yr. CAGR % | -31.99 | -6.83 | 7.37 | 37.13 | 22.73 | |||||
EBITDA, 3 Yr. CAGR % | 67.37 | 42.88 | 25.74 | 1.78 | -16.05 | |||||
EBITA, 3 Yr. CAGR % | 66.75 | 45.15 | 25.52 | -3 | -16.06 | |||||
EBIT, 3 Yr. CAGR % | 65.09 | 45.15 | 25.52 | -3 | -16.06 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 63.19 | 44.32 | 25.99 | -1.61 | -14.82 | |||||
Net Income, 3 Yr. CAGR % | 63.19 | 44.32 | 25.99 | -1.61 | -14.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | 63.19 | 44.32 | 25.99 | -1.61 | -14.82 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.63 | -1.41 | 3.15 | -31.23 | -55.7 | |||||
Accounts Receivable, 3 Yr. CAGR % | - | - | 52.86 | -8.45 | -23.01 | |||||
Inventory, 3 Yr. CAGR % | - | - | 111.48 | 90.29 | 33.62 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 45.96 | -14.95 | -28.22 | -42.53 | -72.27 | |||||
Total Assets, 3 Yr. CAGR % | 50.12 | 25.05 | -24.95 | -19.27 | -15.65 | |||||
Tangible Book Value, 3 Yr. CAGR % | 67.98 | 121.29 | -43.25 | -59.31 | -47.69 | |||||
Common Equity, 3 Yr. CAGR % | 67.98 | 121.29 | -43.25 | -59.31 | -47.69 | |||||
Cash From Operations, 3 Yr. CAGR % | 67.44 | 83.64 | 5.53 | 0.8 | -17.26 | |||||
Capital Expenditures, 3 Yr. CAGR % | - | -60.06 | - | - | - | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 21.56 | 170.42 | -13.68 | -0.95 | -5.15 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 21.96 | 159.76 | -14.45 | -2.31 | -5.93 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 14.11 | 27.95 | 6.38 | 0.49 | 18.41 | |||||
Gross Profit, 5 Yr. CAGR % | 0.62 | 18.16 | -3.51 | -5.93 | 19.49 | |||||
EBITDA, 5 Yr. CAGR % | 53.75 | 53.21 | 39.8 | 18.87 | 3.93 | |||||
EBITA, 5 Yr. CAGR % | 51.33 | 50.17 | 39.42 | 18.94 | 3.82 | |||||
EBIT, 5 Yr. CAGR % | 51.33 | 50.17 | 38.58 | 18.94 | 3.82 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 50.83 | 49.31 | 38.12 | 19.53 | 4.62 | |||||
Net Income, 5 Yr. CAGR % | 50.83 | 49.31 | 38.12 | 19.53 | 4.62 | |||||
Normalized Net Income, 5 Yr. CAGR % | 50.83 | 49.31 | 38.12 | 19.53 | 4.62 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 7.79 | 2.5 | -22.41 | -33.5 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | 87.99 | - | - | 1.95 | |||||
Inventory, 5 Yr. CAGR % | - | 103.66 | - | - | 59.3 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 25.81 | 19.32 | 8.25 | -31.35 | -58.28 | |||||
Total Assets, 5 Yr. CAGR % | 60.37 | 50.71 | 12.12 | 2.06 | -14.77 | |||||
Tangible Book Value, 5 Yr. CAGR % | 124.6 | 106.26 | 1.91 | -4.42 | -36.5 | |||||
Common Equity, 5 Yr. CAGR % | 108.47 | 100.19 | 1.91 | -4.42 | -36.5 | |||||
Cash From Operations, 5 Yr. CAGR % | - | - | 45.97 | 37.39 | -9.38 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | 16.5 | 69.2 | -8.65 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | 16.21 | 63.65 | -9.1 |
- Stock Market
- Stocks
- MONI Stock
- Financials Monivent AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















